Control of microglial neurotoxicity by the fractalkine receptor
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microglia were labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under the control of fractalkine receptor, CX3CR1, expression (Figure 1, S1, and S5) (Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Cardona et al., 2006
In the citing paper
“microglia are uniformly CX3CR1+ from early embryonic time points through adulthood (Cardona et al., 2006; Ginhoux et al., 2010; Schulz et al., 2012)”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Cardona et al., 2006
In the citing paper
“Conflicting evidence in the literature suggests either neurotoxic or neuroprotective effects of CX3CR1 deletion in various disease models (Cardona et al., 2006; Fuhrmann et al., 2010).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“Our findings support the concept that fractalkine through its receptor CX3CR1 (Harrison et al., 1998) acts as a repressor of microglia activation (Cardona et al., 2006).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“While CX3CR1 is expressed by many leukocyte cell types in the periphery, 15 in the brain CX3CR1 is exclusively expressed by microglia 13 whereas CX3CL1 is highly expressed within neurons.14”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [13]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundMicroglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“In response to injury, microglial cells undergo rapid morphological and functional activation and acquire properties of mature myeloid cells, including antigen presentation, reactive species generation, matrix metalloproteinase (MMP) expression and phagocytosis, as well as cytokine and growth factor secretio”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“However, peripheral immune and inflammatory reactions are mostly unaltered in Cx3cr1 −/− or Cx3cl1 −/− mic”
BackgroundSelf-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Based on these and other findings, efforts to develop pharmacological inhibitors of CX3CR1 are in progres”
BackgroundSelf-citationCX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611 · cited 2×
“Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.”
BackgroundSelf-citationMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Results Neuronal damage in Cx3cr1 −/− mice after systemic LPS We first examined the GFP + population in the CNS of Cx3cr1 GFP mice and found that green fluorescent cells overlapped precisely with brain cells expressing microglial markers such as ionized calcium-binding adapter molecule-1 (IBA-1”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“dtd" [ ]> CX3CR1 is expressed by monocytes, dendritic cells (DCs), and subsets of T cells and natural killer cells in the circulation and by microglia in the central nervous system (CNS”
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 1×
“Knockdown of TREM2 in mouse microglia impairs their phagocytic activity and enhances inflammatory gene expression, suggesting a mechanism for the human disorde”
Background
Cited by
Items 901–1,000 of 1,003
Vocht, N. D., Praet, J., Reekmans, K., Blon, D. L., Hoornaert, C., Daans, J., Berneman, Z. N., der Linden, A. V., & Ponsaerts, P. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt312 · Cited by 31
“On the other hand, the complete depletion of CX3CR1 has been demonstrated to worsen Parkinson’s disease, amyotrophic lateral sclerosis [71], experimental autoimmune encephalomyelitis (EAE) [72] and Alzheimer’s disease [73].”
Backgroundmembership, C., Rudyk, C., Dwyer, Z., & Hayley, S. P. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1483-7 · Cited by 31
New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis
Chiot, A., Lobsiger, C. S., & Boillée, S. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000729 · Cited by 36
“Membranebound fractalkine is considered as the main actor to keep microglia in a homeostatic, nonactivated state [36].”
BackgroundRichter, M., Vidovic, N., Biber, K., Dolga, A., Culmsee, C., & Dodel, R. (2020) · Brain Pathology · doi:10.1111/bpa.12807 · Cited by 29
“However, one of the great disadvantages of the use of isolated microglial cultures is the lack of inhibitory signals that arise from neurons (7, 32, 37).”
BackgroundLi, A., Zhao, J., Fan, C., Zhu, L., Huang, C., Li, Q., Gan, D., Wen, C., Chen, M., & Lu, D. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.012 · Cited by 32
Chrysanthou, M., Estruch, I. M., Rietjens, I. M. C. M., Wichers, H. J., & Hoppenbrouwers, T. (2022) · Nutrients · doi:10.3390/nu14020363 · Cited by 34
Ma, B., Yu, J. H., Xie, C., Sun, L., Lin, S., Ding, J., Luo, J., & Cai, H. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2455-14.2015 · Cited by 30
“LPSs can disrupt the blood– brain barrier and induce activation of microglia in the rodent brains (Wispelwey et al., 1988; Cardona et al., 2006).”
BackgroundExacerbation of Facial Motoneuron Loss after Facial Nerve Axotomy in CCR3-Deficient Mice
Wainwright, D. A., Xin, J., Mesnard, N. A., Beahrs, T. R., Politis, C. M., Sanders, V. M., & Jones, K. J. (2009) · ASN NEURO · doi:10.1042/an20090017 · Cited by 31
“Previous reports have suggested that the chemokine receptors CXCR2, CCR5 and CX3CR1 have the potential to modulate neuronal survival after an injury (Meucci et al., 2000; Cardona et al., 2006; Vallès et al., 2006; Gamo et al., 2008).”
Fractalkine Gene Receptor Polymorphism in Patients With Multiple Sclerosis
Arlı, B., Ceyla, I., Menevşe, S., Yılmaz, A., & Alp, E. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.723079 · Cited by 29
“When stimulated by tumor necrosis factor-alpha (TNFα) and interferon gamma (IFNγ ), fractalkine is synthesized in microglia and astrocytes [6].”
BackgroundParekh, S., & Kaur, T. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1308823 · Cited by 34
Tang, J., Miao, H., Jiang, B., Chen, Q., Tan, L., Tao, Y., Zhang, J., Gao, F., Feng, H., Zhu, G., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.027 · Cited by 29
“Early studies have not reported a role of CX3CR1 in the healthy brain, but recent animal studies have suggested that CX3CR1 deficiency might play negative roles in adult neurogenesis and hippocampus circuit integrity (Bachstetter et al., 2011; Cardona et al., 2006).”
Kiely, A. P., Murray, C. E., Foti, S. C., Benson, B. C., Courtney, R. J., Strand, C., Lashley, T., & Holton, J. L. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly035 · Cited by 30
“The expression of CX3CL1 and CX3CR1 can be altered in the presence of injury or insult (20–22) and impaired CX3CR1 function may exacerbate neurodegeneration (23).”
BackgroundDual functions of microglia in the formation and refinement of neural circuits during development
Konishi, H., Kiyama, H., & Ueno, M. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.09.009 · Cited by 35
“In Squarzoni et al., microglial activation was thought to be impaired in DAP12- and CX3CR1-deficient mice (Cardona et al., 2006; Kobayashi et al., 2016; Konishi and Kiyama, 2018; Mecca et al., 2018), suggesting that microglial dysfunction resulted in the mislocalization of Lhx6+ interneurons (Fig.”
BackgroundCarvalho, T. G., Alves‐Silva, J., de Souza, J. M., Real, A. L. C. V., Doria, J. G., Vieira, É. L. M., Gomes, G. F., de Oliveira, A. C., de Miranda, A. S., & Ribeiro, F. M. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.020 · Cited by 28
“In a model of Parkinson's Disease and in a transgenic mouse model of amyotrophic lateral sclerosis, the CX3CR1 group showed more neuronal cell loss than control and intense inflammatory processes (Cardona et al., 2006).”
Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis
Calafatti, M., Cocozza, G., Limatola, C., & Garofalo, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1223096 · Cited by 34
“The fractalkine receptor (CX3CR1), a chemokine receptor expressed by microglia, monocytes, dendritic cells, and subsets of T cells, was involved in microglial neurotoxicity (125), and consistently, was reduced in mice lacking CD4 T cells and increased following bone marrow reconstitution (125).”
BackgroundExercise, Spinal Microglia and Neuropathic Pain: Potential Molecular Mechanisms
Wang, M., Jing, X.-Y., Wang, Y., Yang, B., Lu, Q., Hu, H., & Kang, L. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04025-4 · Cited by 34
“Interestingly, in contrast to its pro-injury effect in NPP, it has been shown that the neuronal fractalkine/microglial CX3CR1 system has a neuroprotective effect in diseases associated with neurodegeneration [63].”
ResultZhu, Y., Li, L., Jin, X., Li, Z., Wang, C., Teng, L., Li, Y., Zhang, Y., & Wang, D. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128819 · Cited by 31
Analyses of Microglia Effector Function Using CX3CR1-GFP Knock-In Mice
Garcia, J. A., Cardona, S. M., & Cardona, A. E. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-520-0_27 · Cited by 30
“In the CNS, microglia are the only cells that express CX3CR1, also known as the fractalkine receptor (4).”
BackgroundSelf-citationKezic, J. M., & McMenamin, P. G. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5325 · Cited by 28
“59 Our study of the role of CX3CR1 in EAU is timely in light of emerging evidence that has implicated fractalkine-CX3CR1 interactions in microglial-mediated neuroprotective mechanisms in the brain during episodes of systemic inflammation.(60,61) The present study used a novel strategy whereby EAU was induced four week…”
MethodInteraction of microglia with the microenvironment in spinal cord injury
Timofeeva, A. V., Akhmetzyanova, E. R., Rizvanov, A. A., & Mukhamedshina, Y. O. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.074 · Cited by 30
Microglial activation and neuroinflammation in acute and chronic cognitive deficits in sepsis
Denver, P., & Cunningham, C. M. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110285 · Cited by 37
Functional genomics of human brain development and implications for autism spectrum disorders
Ziats, M. N., Grosvenor, L. P., & Rennert, O. M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.153 · Cited by 32
Townsend, B. E., Chen, Y.-J., Jeffery, E. H., & Johnson, R. W. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.10.001 · Cited by 29
“CX3CR1 knockout mice have a similar response to LPS treatment as to that observed in aged animals [28,43,44].”
Microglial Activation and Cannabis Exposure
Cutando, L., Maldonado, R. J., & Ozaita, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00047-8 · Cited by 29
Kane, C. J. M., Douglas, J. C., Rafferty, T. M., Johnson, J. W., Niedzwiedz‐Massey, V. M., Phelan, K. D., Majewska, A. K., & Drew, P. D. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24797 · Cited by 28
Genetic ablation of Nrf2 exacerbates neurotoxic effects of acrylamide in mice
Ekuban, F. A., Zong, C., Takikawa, M., Morikawa, K., Sakurai, T., Ichihara, S., Itoh, K., Yamamoto, M. P., Ohsako, S., & Ichihara, G. (2021) · Toxicology · doi:10.1016/j.tox.2021.152785 · Cited by 29
Zhang, S., Liang, R., Zhou, F., Huang, X., Ding, J., & Hu, G. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9560-6 · Cited by 27
“Emerging evidence showed that rotenone could alter astrocytic function (Diaz-Corrales et al. 2005) and astrocytes had an active role in DA neuronal degeneration ( Cardona et al. 2006; McGeer and McGeer 2008).”
BackgroundMocchetti, I., Campbell, L. A., Harry, G. J., & Avdoshina, V. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9353-4 · Cited by 30
“This suggests that activated microglia and released chemokines could be beneficial for recruiting other cells in order to prevent any further damage to the infected brain (Cardona et al. 2006).”
Bedoui, Y., Neal, J. W., & Gasque, P. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9793-6 · Cited by 28
Quarta, A., Blon, D. L., D’aes, T., Pieters, Z., Taj, S. H., Miró‐Mur, F., Luyckx, E., Breedam, E. V., Daans, J., Goossens, H., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.09.009 · Cited by 31
“Within the context of neuro-inflammatory disease, forced alternative activation of resident microglia and infiltrating monocytes is therefore expected to become a new therapeutic approach (Cherry et al., 2014; Gupta et al., 2018; Hu et al., 2015; Kanazawa et al., 2017; Rajkovic et al., 2018).”
Anastasio, T. J. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00116 · Cited by 26
“For example, using superoxide and in vitro phagocytosis assays, microglia from young mice were shown to respond to fibrillar A β by increasing both ROS production and phagocytosis (Wilkinson et al., 2006).”
MethodLiu, Y., Wang, C., Wang, Q., Lin, Y., Ge, Y., Li, D., & Mao, G. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.06.012 · Cited by 27
RetractedSobuś, A., Baumert, B., Litwińska, Z., Gołąb-Janowska, M., Stępniewski, J., Kotowski, M., Pius‐Sadowska, E., Kawa, M. P., Gródecka-Szwajkiewicz, D., Peregud-Pogorzelski, J. W., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051312 · Cited by 28
“The miR-155 upregulation could be due to the lack of CX3CL1 inhibitory input from neurons, essential for the microglia surveilling phenotype [68].”
BackgroundRhoA balances microglial reactivity and survival during neuroinflammation
Socodato, R., Rodrigues-Santos, A., Tedim-Moreira, J., Almeida, T. O., Canedo, T., Portugal, C. C., & Relvas, J. B. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06217-w · Cited by 30
“Con fi rming previous results [24], following tamoxifen administration, RhoA gene inactivation effectively occurred in microglia from RhoA fl / fl :Cx3cr1 CreER + mice (Fig.”
InfluentialWang, D., Tian, T., Dong, Q., Xu, X., Yu, H., Wang, Y., & Chen, Z.-Y. (2013) · Hippocampus · doi:10.1002/hipo.22204 · Cited by 27
“CX3CL1 has been reported to reduce the microglial activation and to inhibit the release of inflammatory cytokines (Cardona et al., 2006; Biber et al., 2007).”
BackgroundDenoyer, A., Godefroy, D., Célérier, I., Frugier, J., Riancho, L., Brignole‐Baudouin, F., Rostène, W. H., & Baudouin, C. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.43 · Cited by 30
Große, G. M., Tryc, A. B., Dirks, M., Schuppner, R., Pflugrad, H., Lichtinghagen, R., Weißenborn, K., & Worthmann, H. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-74 · Cited by 26
“In inflammatory states of the brain, FKN probably acts via modulatory effects on microglia [12,13], which exert crucial activities in the response after ischemia.”
BackgroundNeuro-Immune Crosstalk in CNS Diseases
Kerschensteiner, M., Meinl, E., & Hohlfeld, R. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_6 · Cited by 28
Calvo, A., Moglia, C., Canosa, A., Cammarosano, S., Ilardi, A., Bertuzzo, D., Traynor, B. J., Brunetti, M., Barberis, M., Mora, G., et al. (2018) · Muscle & Nerve · doi:10.1002/mus.25653 · Cited by 26
Microglia and neurogenesis in the epileptic dentate gyrus
Luo, C., Ikegaya, Y., & Koyama, R. (2016) · Neurogenesis · doi:10.1080/23262133.2016.1235525 · Cited by 28
Vishnumukkala, T., Nassir, C. M. N. C. M., Hein, Z. M., Gopalakrishna, P. K., Karikalan, B., Alkatiri, A., Jagadeesan, S., Naik, V. R., Thomas, W., Moklas, M. A. M., et al. (2025) · Cells · doi:10.3390/cells14191497 · Cited by 32
“Mice with MPTP lesions and CX3CR1 impairment demonstrate increased loss of dopaminergic neurons [115].”
HIV-1 strategies to overcome the immune system by evading and invading innate immune system
Alqudah, M. A. Y., Yaseen, M. M., & Yaseen, M. M. S. (2015) · HIV & AIDS Review · doi:10.1016/j.hivar.2015.07.004 · Cited by 25
Review: Microglia in motor neuron disease
Ashford, B., Boche, D., Cooper‐Knock, J., Heath, P. R., Simpson, J. E., & Highley, J. R. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12640 · Cited by 28
Tahmasebi, F., Pasbakhsh, P., Barati, S., Madadi, S., & Kashani, I. R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30090 · Cited by 25
“The results showed latency to fall (Chang et al., 2017).”
Banerjee, J., Dorfman, M. D., Fasnacht, R. D., Douglass, J. D., Wyse‐Jackson, A. C., Barría, A., & Thaler, J. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126380 · Cited by 26
“In the CNS, the chemokine CX3CL1 (also known as fractalkine) is produced by neurons as both a membrane-bound full-length isoform and a soluble peptide released upon cleavage of the N-terminal domain.”
BackgroundInfluentialTrinh, T. L., Adams, W. A., Calescibetta, A. R., Tu, N., Dalton, R., So, T., Wei, M., Ward, G., Костенко, Е., Christiansen, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106443 · Cited by 26
D’Arrigo, A., Colavito, D., Peña‐Altamira, E., Fabris, M., Dam, M., Contestabile, A., & Leon, A. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9332-2 · Cited by 26
“Many of these mutants retain enzymatic activity ( Bruijn et al. 2004; Pasinelli and Brown 2006), while SOD1 knockout mice do not develop motor disease (Reaume et al. 1996).”
BackgroundCirculating Fractalkine Levels Predict the Development of the Metabolic Syndrome
Yin, X., Zhang, S., Dan, Y., Pan, Q., Dong, X., Jiaqiang, Z., Fenping, Z., & Li, H. (2014) · International Journal of Endocrinology · doi:10.1155/2014/715148 · Cited by 28
“Fractalkine expression has been detected in activated or stressed endothelial, smooth muscle cells, skeletal muscle, macrophages, neurons, hepatocytes [8–12], and adipocytes [13].”
Xiao, F., Xu, J., & Jiang, X. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.156979 · Cited by 26
“…diverse models of neurological disorders, such as neuropathic pain (Sun et al., 2007), age-related macular degeneration (Combadière et al., 2007), peripheral lipopolysaccharide injection-induced intracranial inflammation, Parkinson’s disease and amyotrophic lateral sclerosis (Cardona et al., 2006).”
BackgroundAbdolvahabi, A., Shi, Y., Rasouli, S., Croom, C. M., Aliyan, A., Martí, A. A., & Shaw, B. F. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00029 · Cited by 26
Contributions of Microglia to Structural Synaptic Plasticity
Kim, K. H., Son, S. M., & Mook‐Jung, I. (2013) · Journal of Experimental Neuroscience · doi:10.4137/jen.s11269 · Cited by 30
Bemiller, S. M., Maphis, N. M., Formica, S. V., Wilson, G. N., Miller, C. M., Xu, G., Kokiko-Cochran, O. N., Kim, K.-W., Jung, S., Cannon, J. L., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1310-6 · Cited by 24
Self-citationMicroglia in retinal diseases: From pathogenesis towards therapeutic strategies
Xiao, R., Huang, X., Gao, S., Duan, J., Zhang, Y., & Zhang, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116550 · Cited by 34
Revisiting the critical roles of reactive microglia in traumatic brain injury
Zhao, J., Zhou, Y., Zhou, C.-W., Zhan, K., Yang, M., Wen, M., & Zhu, L. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002420 · Cited by 36
Wang, Y., Chen, H., Fu, Y., Ai, A., Xue, S., Lyu, Q., & Kuang, Y. (2013) · Europe PMC (PubMed Central) · Cited by 29
Xu, K., Chen, S., Xie, L., Qiu, Y., Bai, X., Liu, X., Zhang, H., Wang, X., Jin, Y., Sun, Y., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.597769 · Cited by 24
“However, genetic deficiency of CX3CR1 is associated with potentially detrimental secretion of proinflammatory cytokines causing neurotoxicity (Cardona et al., 2006).”
BackgroundMicroglia in motor neuron disease: Signaling evidence from last 10 years
Wang, M., Lu, K., Wang, Y., Yang, B., Zhang, C., Lu, Y., & Kang, L. (2022) · Developmental Neurobiology · doi:10.1002/dneu.22905 · Cited by 26
LI, G., Hattermann, K., Mentlein, R., Mehdorn, H. M., & Held‐Feindt, J. (2012) · Oncology Reports · doi:10.3892/or.2012.2164 · Cited by 24
“It is one of the most expressed chemokines in the brain (17,20,38,39).”
BackgroundHow dependent is synaptic plasticity on microglial phenotype?
Jones, R. S., & Lynch, M. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.08.012 · Cited by 26
“The largely complementary expression of fractalkine on neurons and its receptor on microglia (Harrison et al., 1998) suggests an interaction similar to that described for CD200- CD200R, and evidence to support this has been reported (Cardona et al., 2006; Lyons et al., 2009a).”
BackgroundJinno, S., & Yamada, J. (2011) · Neuron Glia Biology · doi:10.1017/s1740925x11000135 · Cited by 25
Sabilallah, M., Fontanaud, P., Linck, N., Boussadia, B., Peyroutou, R., Lasgouzes, T., Rassendren, F. A., Marchi, N., & Hirbec, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150793 · Cited by 28
“C57BL/6J CX3CR1 mice were used as microglial cells express the green fluorescent protein (eGFP) while retaining normal functional properties [13], therefore amenable to study microglial activation during seizures [6,13,14].”
MethodObesity and dysregulated central and peripheral macrophage–neuron cross‐talk
Boura‐Halfon, S., Pecht, T., Jung, S., & Rudich, A. (2018) · European Journal of Immunology · doi:10.1002/eji.201747389 · Cited by 25
Self-citationMicroglia Are Necessary to Regulate Sleep after an Immune Challenge
Rowe, R. K., Green, T. R. F., Giordano, K. R., Ortiz, J. B., Murphy, S. M., & Opp, M. R. (2022) · Biology · doi:10.3390/biology11081241 · Cited by 30
Strategies for Manipulating Microglia to Determine Their Role in the Healthy and Diseased Brain
Parajuli, B., & Koizumi, S. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03742-6 · Cited by 25
Microglial phagocytosis of single dying oligodendrocytes is mediated by CX3CR1 but not MERTK
Olveda, G. E., Barasa, M. N., & Hill, R. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114385 · Cited by 26
Gerber, Y. N., Sabourin, J.-C., Hugnot, J., & Perrin, F. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045503 · Cited by 29
“Microglia are recruited at neurodegeneration sites and are known to exert dual effects on neuronal survival notably by releasing pro- or anti- apoptotic factors [37,38].”
BackgroundMicroglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities
Olajide, T. S., Oyerinde, T. O., Omotosho, O. I., Okeowo, O. M., Olajide, O. J., & Ijomone, O. M. (2024) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.56 · Cited by 25
“It has been observed that A β 1 – 42 facilitates the reduction of redox ‐ inactive ferric iron (Fe 3+ ), present as ferrihydrite, into redox ‐ active ferrous iron (Fe 2+ ).”
Modulation of inflammatory responses by fractalkine signaling in microglia
Inoue, K., Morimoto, H., Ohgidani, M., & Ueki, T. (2021) · PLOS ONE · doi:10.1371/journal.pone.0252118 · Cited by 22
“Given that mice with defective CX3CR1 in microglia show various neurological symptoms under various forms of stress [11, 46], the stress-induced behavioral changes may have been partially due to the stimuli-induced CX3CR1 downregulation.”
BackgroundAmantea, D., Russa, D. L., Frisina, M., Giordano, F., Santo, C. D., Panno, M. L., Pignataro, G., & Bagetta, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.825834 · Cited by 24
“In particular, ischemic PC triggers microglia proliferation in the ipsilateral cortex in the absence of tissue infarction, a process dependent on signalling through the fractalkine receptor CX3CR1 (25).”
BackgroundNahum, K., Todder, D., Zohar, J., & Cohen, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137185 · Cited by 25
“CX3CR1 signaling acts as a protector against microglial neurotoxicity, and CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity [70].”
BackgroundMicroglia: Friends or Foes in Glaucoma? A Developmental Perspective
Ahmad, I., & Subramani, M. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac077 · Cited by 23
Church, K. A., Rodriguez, D., Mendiola, A. S., Vanegas, D., Gutiérrez, I. L., Tamayo, I. M., Amadu, A., Velazquez, P., Cardona, S. M., Gyoneva, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1130735 · Cited by 22
Self-citationKezic, J. M., & McMenamin, P. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068570 · Cited by 22
“In mouse experimental autoimmune encephalomyelitis (EAE), earlier disease onset and increased disease severity was observed in Cx 3 cr1 gfp/gfp mice [8], whilst the neutralization of CX 3 CL1 led to exaggerated LPS-induced neuroinflammation [9,10].”
BackgroundCX3CL1/fractalkine is a novel regulator of normal and malignant human B cell function
Corcione, A., Ferretti, E., & Pistoia, V. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112035 · Cited by 28
“gand [27], whereas microglial cells express the receptor [28].”
BackgroundTristão, F. S. M., Lazzarini, M., Martin, S., Amar, M., Stühmer, W., Kirchhoff, F., Gomes, L. C., Lanfumey, L., Prediger, R. D., Sepulveda-Diaz, J. E., et al. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9557-5 · Cited by 23
Marelli, G., Belgiovine, C., Mantovani, A., Erreni, M., & Allavena, P. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.07.013 · Cited by 24
“On the other hand, in the central nervous system, it has been reported that CX3CR1+ microglial cells are kept in check by the neuron-derived ligand (CX3CL1) to prevent excess inflammation that may lead to neuron injury (Cardona et al., 2006; Lampron et al., 2015).”
BackgroundNoradrenaline induces CX3CL1 production and release by neurons
Madrigal, J. L. M., Caso, J. R., García‐Bueno, B., Gutiérrez, I. L., & Leza, J. C. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.001 · Cited by 21
“…of NA modulation of astroglial production of chemokines (Hinojosa et al., 2013; Madrigal et al., 2009), led us to focus on CX3CL1 due to its well-known ability to communicate neurons with microglia and repress the activation of the last ones (Cardona et al., 2006; Nishiyori et al., 1998).”
New concepts in macrophage ontogeny in the adult neural retina
Saban, D. R. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.04.008 · Cited by 22
Perkins, A. E., Varlinskaya, E. I., & Deak, T. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.08.001 · Cited by 24
“In addition to detection of pathogens, microglia also respond to inhibitory signals secreted by neighboring neurons, such as fractalkine (CX3CL1) and CD200, both of which serve to maintain microglia in a quiescent state and tonically suppress microglial activation (Cardona et al., 2006).”
BackgroundNon-coding RNAs in Ischemic Stroke: Roles in the Neuroinflammation and Cell Death
Lü, M., Xingang, D., Zhang, Z., Li, W., & Khoshnam, S. E. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00236-7 · Cited by 25
“They showed that the in vivo ischemic stroke model significantly increased proinflammatory factors including E-selectin, MCP-1, and IL-6.”
BackgroundInfluentialHurst, L. A., Bunning, R. A. D., Sharrack, B., & Woodroofe, M. N. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.05.057 · Cited by 24
T-cell responses to neurofilament light protein are part of the normal immune repertoire
Huizinga, R., Hintzen, R. Q., Assink, K., van Meurs, M., & Amor, S. (2009) · International Immunology · doi:10.1093/intimm/dxp011 · Cited by 25
Carelli, S., Giallongo, T., Gombalová, Z. T., Rey, F., Gorio, M. C., Mazza, M., & Giulio, A. M. D. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1375-2 · Cited by 25
Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s Disease
Grimmig, B., Morganti, J., Nash, K., & Bickford, P. (2016) · Brain Sciences · doi:10.3390/brainsci6040041 · Cited by 17
“It has been demonstrated that maintaining or enhancing communication of FKN/CX3CR1 is neuroprotective in multiple rodent models of PD. Pabon et al. (2011) [37] attenuated the neurotoxicity of 6 hydroxydopamine (6OHDA) by delivering a chronic intrastriatal infusion of recombinant fractalkine ligand.”
BackgroundInfluentialRodríguez, M., & Mahy, N. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867324666161123091314 · Cited by 21
New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis
Pampalakis, G., Mitropoulos, K. A., Xiromerisiou, G., Dardiotis, E., Deretzi, G., Anagnostouli, M. C., Κάτσιλα, Θ., Rentzos, M., & Patrinos, G. P. (2018) · Human Mutation · doi:10.1002/humu.23697 · Cited by 27
Ge, Y., Yang, J., Chen, J., Dai, M., Dou, X., Yao, S., Yao, C., & Lin, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14551 · Cited by 23
“14 18–20 In this study, we examined the microglial activation in the ipsilateral hippocampal regions, including the number of Iba1 + cells, the size of their nuclei, and the expression of the activation marker CD68.”
BackgroundThe Chemokine (C-C Motif) Ligand 2 in Neuroinflammation and Neurodegeneration
Madrigal, J. L. M., & Caso, J. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_15 · Cited by 22
Doroshenko, E. R., Drohomyrecky, P. C., Gower, A., Whetstone, H., Cahill, L. S., Ganguly, M., Spring, S., Yi, T. J., Sled, J. G., & Dunn, S. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.570425 · Cited by 26
“Although Cx3cr1 heterozygosity is reported not to influence EAE severity (41), given the importance of Cx3cr1 in microglia/neuronal interactions (42), we also compared EAE development between male Cx3cr1CreERT2:Ppardfl/fl mice that had been treated 30 days previous with TAM or vehicle.”
BackgroundCohen, E. M., Mohammed, S., Kavurma, M. M., Nedoboy, P. E., Cartland, S. P., Farnham, M. M. J., & Pilowsky, P. M. (2018) · Autonomic Neuroscience · doi:10.1016/j.autneu.2018.12.002 · Cited by 22
Cui, S., Sun, H., Gu, X., Lv, E., Zhang, Y., Dong, P., Fu, C., & Zhu, C. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1889-z · Cited by 23
“Besides, loss of CX3CR1 on microglia induces neurotoxicity in mouse models of systemic inflammation in PD [23].”
BackgroundRetractedvan der Maten, G., Henck, V., Wieloch, T. W., & Ruscher, K. (2017) · BMC Neuroscience · doi:10.1186/s12868-016-0325-0 · Cited by 22
“Relevance of CX3CR1 for immune cell activation after stroke It has been shown that activation of the CX3CR1 receptor is involved in microglia/leukocyte trafficking [10, 16, 19, 25, 26] and phagocytosis [23, 27].”
BackgroundKim, M., Jung, K., Ko, Y., Kim, I., Hwang, K., Jang, J., Shin, J. E., & Park, K. I. (2020) · Cells · doi:10.3390/cells9051195 · Cited by 22
“The deletion of CX3CR1 expression could promote microglial activation, and enhancement of CX3CR1 expression could protect against microglial neurotoxicity in the model of Parkinson’s disease and a transgenic model of amyotrophic lateral sclerosis [67].”
BackgroundYousefian-Jazi, A., Sung, M. K., Lee, T., Hong, Y., Choi, J. K., & Choi, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-69790-6 · Cited by 21
Ruchaya, P. J., Antunes, V. R., Paton, J. F. R., Murphy, D., & Yao, S. T. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2013.075432 · Cited by 21
“This finding, coupled with the fact that CX3CR1 receptors are predominantly located in microglia, as demonstrated in the CX3CR1-GFP mouse model (Cardona et al. 2006), suggests that the increase might stem from upregulation or activation of microglia (Rana et al. 2010).”
BackgroundResultMicroglia of the Brain: Origin, Structure, Functions
Alekseeva, O. S., Kirik, O. V., Gilerovich, E. G., & Korzhevsky, D. E. (2019) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s002209301904001x · Cited by 21
Glial-mediated neuroinflammatory mechanisms in age-related macular degeneration
Dhodapkar, R. M., Martell, D., & Hafler, B. P. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00939-3 · Cited by 21
Macrophage orchestration of epithelial and stromal cell homeostasis in the intestine
Cao, Q., Mertens, R. T., Sivanathan, K. N., Cai, X., & Xiao, P. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0322-176r · Cited by 21
Kawamura, N., Katsuura, G., Yamada-Goto, N., Nakama, R., Kambe, Y., Miyata, A., Furuyashiki, T., Narumiya, S., Ogawa, Y., & Inui, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-16944-3 · Cited by 23
Targeting foam cell formation to improve recovery from ischemic stroke
Zbesko, J. C., Stokes, J., Becktel, D. A., & Doyle, K. P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106130 · Cited by 20
Metadata
- Authors
- Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.-C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- National Institute of Environmental Health Sciences (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ransohoff, Richard M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-06-18
- Volume
- 9
- Issue
- 7
- Pages
- 917-924
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2113107925
- Cited by
- 1,531
- References
- 39
- Citations by year
- 2026: 46 · 2025: 44 · 2024: 84 · 2023: 62 · 2022: 83 · 2021: 73 · 2020: 66 · 2019: 76 · 2018: 95 · 2017: 90 · 2016: 87 · 2015: 102 · 2014: 133 · 2013: 104 · 2012: 90
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS32151, R01NS032151)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microglia, CX3CR1, microglial neurotoxicity, neuroinflammation, lipopolysaccharide, Parkinson's disease, amyotrophic lateral sclerosis, neuronal loss, CX3CR1 knockout mice
- MeSH terms
- CX3C Chemokine Receptor 1, Analysis of Variance, Animals, Calcium-Binding Proteins, Cells, Cultured, Central Nervous System, Disease Models, Animal, Flow Cytometry, Immunohistochemistry, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Nerve Tissue Proteins, Neurons, Parkinson Disease, Cytokines, Motor Neuron Disease, Cell Death, Microglia, Receptors, Chemokine, Neurotoxicity Syndromes, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.